Atlas Trials

Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

Clinical trial NCT00148616 · TERMINATED

Trial details

NCT number
NCT00148616
Sponsor
M. Schaefer, MD
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Schizophrenia
Start date
2004-04-01
Primary completion
2008-06-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.